{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:30Z","timestamp":1792593690317,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.mehy.2017.04.018","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T17:46:56Z","timestamp":1493056016000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?"],"prefix":"10.1016","volume":"103","author":[{"given":"John R.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2017.04.018_b0005","unstructured":"United Nations Office on Drugs and Crime (UNODC). World Drug Report 2016. Available from www.unodc.org\/doc\/wdr2016\/WORLD_DRUG_REPORT_2016_web.pdf. Accessed December 1, 2016."},{"issue":"No. SS-11","key":"10.1016\/j.mehy.2017.04.018_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6511a1","article-title":"National estimates of marijuana use and related indicators \u2014 National Survey on Drug Use and Health, United States, 2002\u20132014","volume":"65","author":"Azofeifa","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.mehy.2017.04.018_b0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-med-050214-013454","article-title":"Marijuana legalization: impact on physicians and public health","volume":"67","author":"Wilkinson","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.mehy.2017.04.018_b0020","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/acem.12655","article-title":"Cyclic vomiting presentations following marijuana liberalization in Colorado","volume":"22","author":"Kim","year":"2015","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.mehy.2017.04.018_b0030","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/gut.2003.036350","article-title":"Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis use","volume":"53","author":"Allen","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.mehy.2017.04.018_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2015.08.051","article-title":"Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure","volume":"34","author":"Argamany","year":"2016","journal-title":"Am J Emerg Med."},{"key":"10.1016\/j.mehy.2017.04.018_b0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/00048679609076108","article-title":"Psychogenic vomiting complicated by marijuana abuse and spontaneous pneumomediastinum","volume":"30","author":"de Moore","year":"1996","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0045","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/ph3072163","article-title":"Cannabinoid-induced hyperemesis: a conundrum-from clinical recognition to basic science mechanisms","volume":"3","author":"Darmani","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.mehy.2017.04.018_b0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1874473711104040241","article-title":"Cannabinoid hyperemesis syndrome","volume":"4","author":"Galli","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.mehy.2017.04.018_b0055","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00221-014-3939-4","article-title":"Adult cyclical vomiting syndrome: a disorder of allostatic regulation?","volume":"232","author":"Levinthal","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.mehy.2017.04.018_b0060","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/MPG.0b013e31802bddb7","article-title":"Autonomic abnormalities in cyclic vomiting syndrome","volume":"44","author":"Chelimsky","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1303\u20137","key":"10.1016\/j.mehy.2017.04.018_b0065","first-page":"e339","article-title":"Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study","volume":"22","author":"Venkatesan","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.mehy.2017.04.018_b0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1651-2227.1998.tb01437.x","article-title":"Precipitants and aetiology of cyclic vomiting syndrome","volume":"87","author":"Withers","year":"1998","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.mehy.2017.04.018_b0075","first-page":"19S","article-title":"Psychological and social characteristics and precipitants of vomiting in children with cyclic vomiting syndrome","volume":"44","author":"Forbes","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mehy.2017.04.018_b0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.59.3.371","article-title":"Cyclic vomit in children: seen through the psychiatrist's eye","volume":"59","author":"Reinhart","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2017.04.018_b0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1526-4610.2007.00997.x","article-title":"Psychiatric symptoms in children and adolescents with cyclic vomiting syndrome and their parents","volume":"48","author":"Tarbell","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.mehy.2017.04.018_b0090","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00221-014-3967-0","article-title":"An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)","volume":"232","author":"Venkatesan","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.mehy.2017.04.018_b0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0022-3476(99)70242-8","article-title":"Is cyclic vomiting syndrome related to migraine?","volume":"134","author":"Li","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.mehy.2017.04.018_b0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.2004.t01-2-04020.x","article-title":"Cyclic vomiting syndrome: anticipatory stress response in migraine?","volume":"44","author":"Gupta","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.mehy.2017.04.018_b0105","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/nmo.12843","article-title":"Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome","volume":"28","author":"Venkatesan","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.mehy.2017.04.018_b0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mayocp.2011.10.005","article-title":"Cannabinoid hyperemesis: a case series of 98 patients","volume":"87","author":"Simonetto","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mehy.2017.04.018_b0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic\u2013pituitary\u2013adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.mehy.2017.04.018_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5688\/aj710478","article-title":"Physiology of the autonomic nervous system","volume":"71","author":"McCorry","year":"2007","journal-title":"Am J Pharm Educ."},{"key":"10.1016\/j.mehy.2017.04.018_b0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness","volume":"24","author":"Herman","year":"2003","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.mehy.2017.04.018_b0130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.mehy.2017.04.018_b0135","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/en.2005-1649","article-title":"Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function","volume":"148","author":"Cota","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2017.04.018_b0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2017.04.018_b0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.irn.2015.09.003","article-title":"Endocannabinoid regulation of neuroendocrine systems","volume":"125","author":"Tasker","year":"2015","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.mehy.2017.04.018_b0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.irn.2015.09.001","article-title":"Endocannabinoid mechanisms influencing nausea","volume":"125","author":"Sticht","year":"2015","journal-title":"Int Rev Neurobiol"},{"issue":"Suppl 8A","key":"10.1016\/j.mehy.2017.04.018_b0155","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0002-9343(01)00849-X","article-title":"Central neurocircuitry associated with emesis","volume":"111","author":"Hornby","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2017.04.018_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-003-0807-0","article-title":"Perturbations in brain monoamine systems during stress","volume":"315","author":"Fl\u00fcgge","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.mehy.2017.04.018_b0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2013.09.075","article-title":"Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders","volume":"722","author":"Bashashati","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0170","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain","volume":"126","author":"Iversen","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2017.04.018_b0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","article-title":"Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors","volume":"361","author":"Nakazi","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1016\/j.mehy.2017.04.018_b0180","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2017.04.018_b0190","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/10253890.2011.586753","article-title":"Endocannabinoids and stress","volume":"14","author":"Riebe","year":"2011","journal-title":"Stress"},{"key":"10.1016\/j.mehy.2017.04.018_b0195","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200509000-00016","article-title":"Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice","volume":"16","author":"Fride","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0200","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2017.04.018_b0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2017.04.018_b0210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00210-004-0921-x","article-title":"Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain","volume":"369","author":"Moranta","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2011.12.010","article-title":"Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase","volume":"38","author":"Fi\u0161ar","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","article-title":"Inhibition of monoamine oxidase activity by cannabinoids","volume":"381","author":"Fi\u0161ar","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0225","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","article-title":"Effects of cannabinoids on neurotransmission","volume":"168","author":"Szabo","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2017.04.018_b0235","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1523\/JNEUROSCI.20-07-02470.2000","article-title":"Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus","volume":"20","author":"Hoffman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2017.04.018_b0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00210-016-1302-y","article-title":"CB(1) receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmission","volume":"390","author":"Grz\u0119da","year":"2017","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1016\/j.mehy.2017.04.018_b0245","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bjp.0703599","article-title":"Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes","volume":"131","author":"Gifford","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0250","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.mehy.2017.04.018_b0255","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1471-4159.1997.69031131.x","article-title":"Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum","volume":"69","author":"Cadogan","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2017.04.018_b0260","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2017.04.018_b0265","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2017.04.018_b0270","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0893-133X(97)00018-3","article-title":"Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966","volume":"16","author":"Jentsch","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2017.04.018_b0275","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/01.wnr.0000236853.40221.8e","article-title":"Cannabinoid self-administration increases dopamine release in the nucleus accumbens","volume":"17","author":"Fadda","year":"2006","journal-title":"NeuroReport"},{"key":"10.1016\/j.mehy.2017.04.018_b0280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-8993(02)03055-X","article-title":"Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study","volume":"948","author":"Pistis","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2017.04.018_b0285","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1460-9568.1998.00292.x","article-title":"Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids","volume":"10","author":"Diana","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2017.04.018_b0290","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.bjp.0705422","article-title":"Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats","volume":"140","author":"Padley","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0295","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0024-3205(99)00016-8","article-title":"Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat","volume":"64","author":"Corchero","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2017.04.018_b0300","doi-asserted-by":"crossref","first-page":"79S","DOI":"10.1023\/A:1026602216846","article-title":"Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis","volume":"44","author":"Tach\u00e9","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mehy.2017.04.018_b0305","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1126\/science.276.5321.2050","article-title":"Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal","volume":"276","author":"Rodr\u00edguez de Fonseca","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mehy.2017.04.018_b0310","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0315","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1615\/CritRevNeurobiol.v15.i2.10","article-title":"Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids","volume":"15","author":"Sim-Selley","year":"2003","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.mehy.2017.04.018_b0320","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.179.4071.391","article-title":"Delta-9-tetrahydrocannabinol: localization in body fat","volume":"179","author":"Kreuz","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.mehy.2017.04.018_b0325","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0330","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pbb.2006.12.020","article-title":"Repeated cannabinoid administration increases indices of noradrenergic activity in rats","volume":"86","author":"Page","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2017.04.018_b0335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.expneurol.2012.05.016","article-title":"Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure","volume":"236","author":"Reyes","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.mehy.2017.04.018_b0340","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1461145705005651","article-title":"Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment","volume":"9","author":"Hill","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0345","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.lfs.2006.12.032","article-title":"Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes","volume":"80","author":"Watanabe","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2017.04.018_b0350","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.prostaglandins.2014.11.002","article-title":"Endocannabinoid metabolism by cytochrome P450 monooxygenases","volume":"116\u2013117","author":"Zelasko","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.mehy.2017.04.018_b0355","first-page":"685","article-title":"The cortisol awakening response and autonomic nervous system activity during nocturnal and early morning periods","volume":"31","author":"Izawa","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.mehy.2017.04.018_b0360","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2011.06.042","article-title":"Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis","volume":"349","author":"Kalsbeek","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2017.04.018_b0365","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1743-3150.2004.00490.x","article-title":"Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function","volume":"16","author":"Tach\u00e9","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.mehy.2017.04.018_b0370","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1523\/JNEUROSCI.5838-09.2010","article-title":"Cannabinoids excite circadian clock neurons","volume":"30","author":"Acuna-Goycolea","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2017.04.018_b0375","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neubiorev.2008.03.004","article-title":"Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders","volume":"32","author":"Gorzalka","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.mehy.2017.04.018_b0380","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2017.04.018_b0385","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cne.23175","article-title":"Brain sources of inhibitory input to the rat rostral ventrolateral medulla","volume":"521","author":"Bowman","year":"2013","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.mehy.2017.04.018_b0390","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/08897077.2015.1052869","article-title":"Catatonia and cannabis withdrawal: a case report","volume":"37","author":"Caudron","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.mehy.2017.04.018_b0395","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17425255.2013.759209","article-title":"Understanding the pharmacokinetics of anxiolytic drugs","volume":"9","author":"Altamura","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.mehy.2017.04.018_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A clinical review of the treatment of catatonia","volume":"5","author":"Sienaert","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0405","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00018-006-6027-5","article-title":"The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction","volume":"63","author":"Laviolette","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mehy.2017.04.018_b0410","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1369-1600.2008.00106.x","article-title":"Cannabis and psychiatric disorders: it is not only addiction","volume":"13","author":"Leweke","year":"2008","journal-title":"Addict Biol"},{"key":"10.1016\/j.mehy.2017.04.018_b0415","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.2174\/1381612822666160826105628","article-title":"Cannabinoids and psychosis","volume":"22","author":"D'Souza","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mehy.2017.04.018_b0420","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1369-1600.2011.00356.x","article-title":"Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study","volume":"17","author":"Leroy","year":"2012","journal-title":"Addict Biol"},{"key":"10.1016\/j.mehy.2017.04.018_b0425","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/mp.2011.187","article-title":"Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of \u03b4-9-tetrahydrocannabinol on midbrain and striatal function","volume":"17","author":"Bhattacharyya","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0430","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1177\/0269881115609073","article-title":"Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of \u03949-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences","volume":"29","author":"Tunbridge","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0435","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-007-1042-2","article-title":"Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans","volume":"198","author":"D'Souza","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2017.04.018_b0440","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pnpbp.2007.10.001","article-title":"Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats","volume":"32","author":"Egashira","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0445","first-page":"3","article-title":"Atypical antipsychotics: sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0450","first-page":"3614053","article-title":"Successful treatment of suspected cannabinoid hyperemesis syndrome using haloperidol in the outpatient setting","volume":"2016","author":"Jones","year":"2016","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2013.02.021","article-title":"Haloperidol for treatment of cannabinoid hyperemesis syndrome","volume":"31","author":"Hickey","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.mehy.2017.04.018_b0460","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/0269881109358200","article-title":"Central nervous system effects of haloperidol on THC in healthy male volunteers","volume":"24","author":"Liem-Moolenaar","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0465","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pbb.2006.05.018","article-title":"Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice","volume":"84","author":"Nagai","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2017.04.018_b0470","doi-asserted-by":"crossref","first-page":"90","DOI":"10.20882\/adicciones.776","article-title":"Cannabinoid hyperemesis syndrome. A report of six new cases and a summary of previous reports","volume":"28","author":"Contreras Narv\u00e1ez","year":"2016","journal-title":"Adicciones"},{"key":"10.1016\/j.mehy.2017.04.018_b0475","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1002\/j.1552-4604.2002.tb06005.x","article-title":"Cardiovascular consequences of marijuana use","volume":"42","author":"Sidney","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0480","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1002\/j.1552-4604.2002.tb06004.x","article-title":"Cardiovascular system effects of marijuana","volume":"42","author":"Jones","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0485","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0022-3565(24)29602-6","article-title":"Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart","volume":"297","author":"Szabo","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2017.04.018_b0490","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/clpt.1982.86","article-title":"Comparison of effects of marihuana cigarettes to three different potencies","volume":"31","author":"Perez-Reyes","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mehy.2017.04.018_b0495","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0091-3057(89)90369-9","article-title":"Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance","volume":"34","author":"Heishman","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2017.04.018_b0500","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00008877-200509000-00023","article-title":"Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids","volume":"16","author":"Ilan","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0505","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0006-3223(93)90171-9","article-title":"Depersonalization after marijuana smoking","volume":"33","author":"Mathew","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0510","doi-asserted-by":"crossref","first-page":"H785","DOI":"10.1152\/ajpheart.00571.2015","article-title":"Endocannabinoids in cerebrovascular regulation","volume":"310","author":"Beny\u00f3","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.mehy.2017.04.018_b0515","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.CIR.53.4.703","article-title":"The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade","volume":"53","author":"Kanakis","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2017.04.018_b0520","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cpt1977213336","article-title":"Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades","volume":"21","author":"Benowitz","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mehy.2017.04.018_b0525","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-91-4-571","article-title":"Lack of cardiovascular effects of delta-9-tetrahydrocannabinol in chemically denervated men","volume":"91","author":"Kanakis","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2017.04.018_b0530","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cpt1979254440","article-title":"Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms","volume":"25","author":"Benowitz","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mehy.2017.04.018_b0535","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1176\/ajp.140.5.626","article-title":"Marked sinus tachycardia resulting from the synergistic effects of marijuana and nortriptyline","volume":"140","author":"Hillard","year":"1983","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0540","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0030-1248314","article-title":"The effects of cannabis on heart rate variability and well-being in young men","volume":"43","author":"Schmid","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.mehy.2017.04.018_b0545","first-page":"297","article-title":"Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions","volume":"46","author":"Bugajski","year":"1995","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0550","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.09.055","article-title":"Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"624","author":"McLaughlin","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0555","first-page":"973","article-title":"Preventive migraine treatment","volume":"21","author":"Silberstein","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.mehy.2017.04.018_b0560","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0269881115612236","article-title":"Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis","volume":"30","author":"Steenen","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2017.04.018_b0565","first-page":"161","article-title":"Prophylaxis of cyclic vomiting with propranolol","volume":"16","author":"Weitz","year":"1982","journal-title":"Drug Intell Clin Pharm."},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2017.04.018_b0570","first-page":"S743","article-title":"Cyclic vomiting syndrome in Thai children","volume":"85","author":"Aanpreung","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.mehy.2017.04.018_b0575","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/MEG.0b013e328355638f","article-title":"The management of cyclic vomiting syndrome: a systematic review","volume":"24","author":"Lee","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mehy.2017.04.018_b0580","first-page":"270","article-title":"Combination of erythromycin and propranolol for treatment of childhood cyclic vomiting syndrome: a novel regimen","volume":"8","author":"Haghighat","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.mehy.2017.04.018_b0585","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4065\/84.1.76","article-title":"Cannabinoid hyperemesis relieved by compulsive bathing","volume":"84","author":"Chang","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mehy.2017.04.018_b0590","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/1947-2714.132935","article-title":"Scientific evidence-based effects of hydrotherapy on various systems of the body","volume":"6","author":"Mooventhan","year":"2014","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.mehy.2017.04.018_b0595","doi-asserted-by":"crossref","unstructured":"Thomas KN, van Rij AM, Lucas SJ, Cotter JD. Lower-limb hot-water immersion acutely induces beneficial hemodynamic and cardiovascular responses in peripheral arterial disease and healthy, elderly controls. Am J Physiol Regul Integr Comp Physiol. 2016 Dec 21:ajpregu.00404.2016. doi: 10.1152\/ajpregu.00404.2016. [Epub ahead of print].","DOI":"10.1152\/ajpregu.00404.2016"},{"key":"10.1016\/j.mehy.2017.04.018_b0600","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1253\/jcj.65.587","article-title":"Effects of hot bath immersion on autonomic activity and hemodynamics: comparison of the elderly patient and the healthy young","volume":"65","author":"Nagasawa","year":"2001","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.mehy.2017.04.018_b0605","first-page":"405238","article-title":"Cannabinoid hyperemesis syndrome: a paradoxical cannabis effect","volume":"2015","author":"Figueroa-Rivera","year":"2015","journal-title":"Case Rep Gastrointest Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717301342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717301342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:57:45Z","timestamp":1750204665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987717301342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":121,"alternative-id":["S0306987717301342"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.04.018","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}